Combined Hemoperfusion and Therapeutic Plasma Exchange for Treatment of Patients With Septic Shock

CompletedOBSERVATIONAL
Enrollment

82

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

December 1, 2023

Study Completion Date

March 1, 2024

Conditions
SepsisSeptic Shock
Interventions
DEVICE

Efferon LPS

"Efferon LPS, a medical device, which is a single-use cartridge filled with a polymeric adsorbent that selectively adsorbs endotoxin via surface-immobilized ligand and excessive cytokines via its intrinsic porosity.~This device is routinely used for extracorporeal therapy of sepsis to improve hemodynamic function and abrogate septic shock.~Plasma exchange procedures will be carried out with a replacement volume of 2 plasma volumes with fresh frozen plasma and albumin solution.~Each patient is scheduled to undergo two separate hemoperfusions lasting 8-10 hours within 48 hours.~60 minutes before the start of hemoperfusion, additional administration of antimicrobial drugs is performed, taking into account their elimination during plasma exchange and adsorption"

DEVICE

Efferon CT

"Efferon CT, a medical device, which is a single-use cartridge filled with a polymeric adsorbent that adsorbs excessive cytokines via its intrinsic porosity.~This device is routinely used for extracorporeal therapy of cytokine storm syndrome in the course of severe SARS-CoV-2.~Plasma exchange procedures will be carried out with a replacement volume of 2 plasma volumes with fresh frozen plasma and albumin solution.~Each patient is scheduled to undergo two separate hemoperfusions lasting 8-10 hours within 48 hours.~60 minutes before the start of hemoperfusion, additional administration of antimicrobial drugs is performed, taking into account their elimination during plasma exchange and adsorption"

Trial Locations (1)

Unknown

City clinical hospital named after S. S. Yudin, Moscow City Health Department, Moscow

All Listed Sponsors
lead

Efferon JSC

INDUSTRY